Skip to Main Content

Author Details

Reina Haque
Southern California Permanente Medical Group
1998
99
31
PMIDPaper TitleJournal TitlePublished Year
36261688Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO.Fam Cancer2023
37605715Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health Plan.Breast Cancer (Dove Med Press)2023
35816026Associations of Health-Related Quality of Life and Sleep Disturbance With Cardiovascular Disease Risk in Postmenopausal Breast Cancer Survivors.Cancer Nurs2023
37044209Associations of dietary isothiocyanate exposure from cruciferous vegetable consumption with recurrence and progression of non-muscle-invasive bladder cancer: findings from the Be-Well Study.Am J Clin Nutr2023
37265450Investigating Mortality Disparities Among Insured Patients With Colon Cancer Treated in an Integrated Health care System and Other Private Settings.Am Surg2023
36911890Developing a Community-Oriented and Place-Based Strategy to Improve COVID-19 Vaccine Accessibility.Perm J2023
36228942Disparities in melanoma-specific mortality by race/ethnicity, socioeconomic status, and health care systems.J Am Acad Dermatol2023
36083407Antidepressant medication use and prostate cancer recurrence in men with depressive disorders.Cancer Causes Control2022
35803481Association of interleukin-8 and risk of incident and recurrent depression in long-term breast cancer survivors.Brain Behav Immun2022
35670038Accelerated mononuclear cell telomere attrition in breast cancer survivors with depression history: A 2-year longitudinal cohort study.Cancer2022
35861620The Influence of Medical Comorbidities on Survival Disparities in a Multiethnic Group of Patients with De Novo Metastatic Breast Cancer.Cancer Epidemiol Biomarkers Prev2022
36449286Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well Study.JAMA Netw Open2022
36394875Association of Physical Activity With Risk of Mortality Among Breast Cancer Survivors.JAMA Netw Open2022
33035108Insomnia and Susceptibility to Depressive Symptoms and Fatigue in Diverse Breast Cancer Survivors.J Womens Health (Larchmt)2021
33539175SARS-CoV-2 Testing, Positivity Rates, and Healthcare Outcomes in a Cohort of 22,481 Breast Cancer Survivors.JCO Clin Cancer Inform2021
33783687Patterns of overall mortality by race/ethnicity and socioeconomic status in insured cancer patients in Southern California.Cancer Causes Control2021
34586512Sleep medication use and risk of fractures in breast cancer survivors.Breast Cancer Res Treat2021
34002959Influence of health care systems on mortality in adult patients with cancer.Am J Manag Care2021
32145911Feasibility, patient compliance and acceptability of ovarian cancer surveillance using two serum biomarkers and Risk of Ovarian Cancer Algorithm compared to standard ultrasound and CA 125 among women with BRCA mutations.Gynecol Oncol2020
32096056Prevalence of mutations in a diverse cohort of 3162 women tested via the same multigene cancer panel in a managed care health plan.J Community Genet2020
33012551Development of a longitudinal two-biomarker algorithm for early detection of ovarian cancer in women with BRCA mutations.Gynecol Oncol2020
30659431Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivors.Breast Cancer Res Treat2019
28610450Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma.Leuk Lymphoma2018
29959604Risk of diabetes complications among those with diabetes receiving androgen deprivation therapy for localized prostate cancer.Cancer Causes Control2018
30405302Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured Women.Ethn Dis2018
29581250LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.Proc Natl Acad Sci U S A2018
28007467Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer.J Urol2017
28259737Medication adherence, molecular monitoring, and clinical outcomes in patients with chronic myelogenous leukemia in a large HMO.J Am Pharm Assoc (2003)2017
29017178Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study.Br J Cancer2017
27900490Discordance between original and central laboratories in ER and HER2 results in a diverse, population-based sample.Breast Cancer Res Treat2017
27100398Cardiovascular Disease After Aromatase Inhibitor Use.JAMA Oncol2016
27084777Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer.World J Urol2016
27002508Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen.Breast Cancer Res Treat2016
25589617A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.Clin Cancer Res2015
26602222Benefit/risk for adjuvant breast cancer therapy with tamoxifen or aromatase inhibitor use by age, and race/ethnicity.Breast Cancer Res Treat2015
26631176Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16,887 Breast Cancer Survivors.J Natl Cancer Inst2015
26355571Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survival.AIDS2015
26475981Statins and hip fracture risk in men: a population-based case-control study.Ann Epidemiol2015
26668177Continuous Combined Estrogen Plus Progestin and Endometrial Cancer: The Women's Health Initiative Randomized Trial.J Natl Cancer Inst2015
26059650Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study.Ann Surg Oncol2015
25625043Treatment patterns for ductal carcinoma in situ from 2000-2010 across six integrated health plans.Springerplus2015
25664181Metformin and breast and gynecological cancer risk among women with diabetes.BMJ Open Diabetes Res Care2015
25757699Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors.Cancer2015
25769058A hybrid approach to identify subsequent breast cancer using pathology and automated health information data.Med Care2015
25524243Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer.J Urol2015
24441675Adherence to endocrine therapy in breast cancer adjuvant and prevention settings.Cancer Prev Res (Phila)2014
25091359Association of body mass index and prostate cancer mortality.Obes Res Clin Pract2014
24939060Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.Breast Cancer Res Treat2014
24512167Comorbidities and cardiovascular disease risk in older breast cancer survivors.Am J Manag Care2014
24638009Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer.J Clin Oncol2014
  • 1 - 50 of 99

Recommended Authors

Memorial Sloan Kettering Cancer Center
Career Start Year 2015
Number of shared co-authors 0
University of Massachusetts Chan Medical School
Career Start Year 2011
Number of shared co-authors 2
San Diego State University School of Public Health
Career Start Year 2011
Number of shared co-authors 0
University of Michigan School of Public Health ann arbor
Career Start Year 2009
Number of shared co-authors 0
Perelman School of Medicine, The University of Pennsylvania
Career Start Year 2005
Number of shared co-authors 2
University of Washington
Career Start Year 2004
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 2
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 1
Columbia University Irving Medical Center
Career Start Year 2004
Number of shared co-authors 1
Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington
Career Start Year 2003
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 2003
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2002
Number of shared co-authors 0
National Cancer Institute, National Institute of Health, 9 Medical Center Drive
Career Start Year 2002
Number of shared co-authors 2
Fred Hutchinson Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 2
Beckman Research Institute of City of Hope
Career Start Year 1997
Number of shared co-authors 3
Stanford University
Career Start Year 1997
Number of shared co-authors 1
Odette Cancer Centre
Career Start Year 1996
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 0
and Clinical Research Center, Morehouse School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Center for Cancer Equity and Engagement, Dana-Farber/Harvard Cancer Center
Career Start Year 1991
Number of shared co-authors 5
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 4
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1987
Number of shared co-authors 0
German Cancer Research Center (DKFZ)
Career Start Year 1984
Number of shared co-authors 6
National Cancer Institute
Career Start Year 1983
Number of shared co-authors 0
Keck School of Medicine, University of Southern California
Career Start Year 1981
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1979
Number of shared co-authors 2
Washington University School of Medicine
Career Start Year 1978
Number of shared co-authors 5
University of California San Francisco
Career Start Year 1968
Number of shared co-authors 3
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Career Start Year 1964
Number of shared co-authors 2

Collaborators

Kaiser Permanente Northern California, University of California san francisco
Co-authored papers 22
Kaiser Permanente Southern California
Co-authored papers 12
Co-authored papers 5
Center for Health Research, Kaiser Permanente Northwest Research Center
Co-authored papers 4
Kaiser Permanente Northern California
Co-authored papers 4
University of Massachusetts Chan Medical School
Co-authored papers 3
Georgetown University
Co-authored papers 3
Brigham and Women's Hospital
Co-authored papers 2
Oregon National Primate Research Center
Co-authored papers 2
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 2
Co-authored papers 2
12286Rutgers - New Jersey Medical School
Co-authored papers 2
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 2
Roswell Park Comprehensive Cancer Center
Co-authored papers 2
Co-authored papers 2
HealthPartners Institute
Co-authored papers 2
Co-authored papers 1
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Co-authored papers 1
University of California irvine
Co-authored papers 1
Kaiser Permanente Northern California, University of California San Francisco
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Co-authored papers 1
Knight Cancer Institute and.
Co-authored papers 1
Huntsman Cancer Institute, University of Utah
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 1
The Chinese University of Hong Kong
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Brody School of Medicine, East Carolina University
Co-authored papers 1